Abiralieva 250mg

Abiralieva 250mg Tablet is indicated for adult men in the management of prostate cancer that has metastasized to other areas of the body. This medication inhibits testosterone production, thereby slowing the progression of prostate cancer. It is typically prescribed during the early stages of the disease when it remains responsive to hormone therapy.

Patients should consult their Physician or Pharmacist if they have liver issues, hypertension, heart failure, or low potassium levels, as these conditions may elevate the risk of heart rhythm disturbances, cardiovascular issues, irregular or rapid heartbeats, shortness of breath, sudden weight gain, swelling in the feet, ankles, or legs, potential bone effects, high blood sugar, or any heart or vascular conditions, including arrhythmias or treatments for such conditions, as well as symptoms like yellowing of the skin or eyes, dark urine, nausea, and vomiting, which may indicate liver problems. In rare cases, liver failure can occur, potentially leading to death.

This medication is not intended for use in children and adolescents. In the event of accidental ingestion, it is crucial to take the patient along with the package leaflet to a doctor immediately. Serious side effects may include muscle weakness, muscle twitching, and palpitations, which are indicative of low potassium levels in the blood. Additionally, a decrease in red blood cells and reduced libido may occur with the use of Abiralieva 250mg Tablet. It is important to never combine Abiralieva 250mg Tablet with Ra-223, a treatment for prostate cancer.